Sangamo to present 9 abstracts at ASGCT 2025, showcasing breakthroughs in neurology and gene regulation
Sangamo Therapeutics, Inc. , a genomic medicine company, announced that the American Society of Gene & Cell Therapy (ASGCT) has accepted nine Sangamo abstracts for presentation at the… read more.
